ARCHIVES

Two New Modalities Promising For Relapsed/Refractory NHL

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

Unique Molecular Profile For Lung Cancer Described

March 31, 2006

In Brief: FDA Deputy Commissioner Friedman Named Senior VP, Clinical Affairs, At G.D. Searle

June 16, 1999

Bailes: ASCO To Strengthen State Affiliates, Begin Quality Of Care Study, Talk With FDA.

May 26, 2000

Intensity Modulated Therapy Safer Than Three-Dimensional Radiation

June 24, 2011

Children’s Cancer Research Institute at UT Health Science Center recruits faculty.

December 10, 2004

Board Oks Construction PA Fro Breast Cancer Research Facilities

July 9, 1993